Terms: = Prostate cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
3 results:
1. Combining PHI and miRNAs as Biomarkers in prostate cancer Diagnosis and Prognosis.
Ibrahim NH; Abdellateif MS; Thabet G; Kassem SH; El-Salam MA; El-Leithy AA; Selim MM
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307177
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.
Heselmeyer-Haddad KM; Berroa Garcia LY; Bradley A; Hernandez L; Hu Y; Habermann JK; Dumke C; Thorns C; Perner S; Pestova E; Burke C; Chowdhury SA; Schwartz R; Schäffer AA; Paris PL; Ried T
Am J Pathol; 2014 Oct; 184(10):2671-86. PubMed ID: 25131421
[TBL] [Abstract] [Full Text] [Related]
3. Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation.
Mauri D; Pentheroudakis G; Tolis C; Chojnacka M; Pavlidis N
Urol Oncol; 2005; 23(5):318-22. PubMed ID: 16144664
[TBL] [Abstract] [Full Text] [Related]